Coloring.app Launches AI-Powered Platform to Convert Photos and Prompts into Custom Printable Coloring Pages and Books 
Scope Technologies Grants Stock Options and Restricted Share Units 
Focus Graphite Advanced Materials Announces Closing of C$891,000 Non-Brokered Private Placement 
Sonim Technologies Reports Second Quarter 2025 Financial Results 
Pineapple Financial Inc. Issues Statement in Response to Recent Market Activity Information expressed in the public domain by the Repharm Group is deceptive and contradictory
Today, on February 19, information has arrived in the public domain that the company from…
CEO of Longeveron Inc. to Present at the Intercontinental Summit on Aging & Gerontology
MIAMI, Feb. 19, 2021 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a…
Yield10 Bioscience Announces Warrant Exercises for Proceeds of $3.8 million
WOBURN, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience…
Intercept to Present at Upcoming Investor Conferences
NEW YORK, Feb. 19, 2021 (GLOBE NEWSWIRE) — Intercept Pharmaceuticals, Inc. (Nasdaq:ICPT), a biopharmaceutical company…
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2020 Financial Results and Business Updates
CAMBRIDGE, Mass., Feb. 19, 2021 (GLOBE NEWSWIRE) — Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical…
Atea Pharmaceuticals Announces Chugai In-License of AT-527 from Roche for the Treatment of COVID-19 in Japan
Chugai obtains exclusive development and marketing rights for AT-527 in Japan from Roche, who has…
RAPT Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — RAPT Therapeutics, Inc. (Nasdaq: RAPT),…
GBT Announces Participation in Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — Global Blood Therapeutics, Inc. (GBT) (NASDAQ:…
CytomX Therapeutics Announces New Employment Inducement Grant
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Vaccinex Announces Signing of Two Multi-Project Deals with Leading Pharmaceutical Companies Focused on Leveraging Its ActivMAb® Platform
Partnerships will use Vaccinex’s ActivMAb® platform for viral display of complex antigens to enable antibody…
BridgeBio Pharma and Affiliate ML Bio Solutions Announce Dosing of First Patient in Phase 2 Trial of BBP-418 in Limb Girdle Muscular Dystrophy Type 2i (LGMD2i)
SAN FRANCISCO, Feb. 19, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a clinical-stage biopharmaceutical company…
Assembly Bio Announces Upcoming Investor Events
SOUTH SAN FRANCISCO, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB),…
Clene Nanomedicine to Present Updated Interim Data from Phase 2 Multiple Sclerosis Programs at ACTRIMS Forum 2021
SALT LAKE CITY, Feb. 19, 2021 (GLOBE NEWSWIRE) — Clene Inc. (NASDAQ: CLNN) (along with…
Precision Announces 3-Year Pre-clinical Study Results Showing Long-term Durability and Safety of ARCUS In Vivo Gene Editing to Cut LDL Cholesterol Levels in Nonhuman Primates
Study Led by Gene Therapy Program at the University of Pennsylvania Published in Molecular Therapy…
Imara to Present at SVB Leerink 10th Annual Global Healthcare Conference
BOSTON, Feb. 19, 2021 (GLOBE NEWSWIRE) — Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company…
Pfizer and BioNTech Submit COVID-19 Vaccine Stability Data at Standard Freezer Temperature to the U.S. FDA
Proposed U.S. EUA label update would enable the vaccine to be stored at -25°C to…
Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2020 Financial Results
BERKELEY HEIGHTS, N.J., Feb. 19, 2021 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ:…
Decibel Therapeutics to Present at the 44th Annual Association for Research in Otolaryngology (ARO) Conference
BOSTON, Feb. 19, 2021 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
BioVie Interview to Air on Bloomberg TV in the US on the RedChip Money Report®
SANTA MONICA, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) — BioVie Inc. (NASDAQ: BIVI) (“BioVie” or…
XBT Provider AB (Publ) Reminds Investors of Upcoming Expiration of Fixed-term Certificates
STOCKHOLM, Sweden, 19 February 2020 /PRNewswire/ — XBT Provider AB (Publ) (“XBT Provider”) part of the…